Treatment of prostatic cancer with monthly injections of an LH-RH analog
Svensson, M.; Varenhorst, E.; Hjertberg, H.; Kågedal, B.; Nordenskjöld, B.
Lakartidningen 84(41): 3270-3271
1987
ISSN/ISBN: 0023-7205 PMID: 2960863 Document Number: 296106
Document emailed within 1 workday
Related Documents
Mathé, G.; Schally, A.V.; Vo Van, M.L.; Duchier, J.; Misset, J.L.; Keiling, R. 1984: An analog of gonadoliberin in the treatment of prostatic carcinoma Presse Medicale 13(23): 1443-1445Bugel, H.; Pfister, C.; Sibert, L.; Cappele, O.; Khalaf, A.; Grise, P. 1999: Intraurethral Macroplastic injections in the treatment of urinary incontinence after prostatic surgery Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 9(6): 1068-1076
Linthorst, G.; Wibaut, E.P.; de Jongh, R.E. 1972: Experiences with a 3-monthly injections of medroxyprogesterone acetate (MPA) as a contraceptive agent Nederlands Tijdschrift Voor Geneeskunde 116(38): 1694-1698
Melo, J.F.; Coutinho, E.M. 1977: Inhibition of spermatogenesis in men with monthly injections of medroxyprogesterone acetate and testosterone enanthate Contraception 15(6): 627-634
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700
Wenderoth, U.K.; Jacobi, G.H. 1986: Treatment of advanced cancer of the prostate with an analog of LHRH, buserelin Annales d'Urologie 20(2): 95-97
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Smith, I.E.; Harland, S.J.; Robinson, B.A.; Evans, B.D.; Goodhart, L.C.; Calvert, A.H.; Yarnold, J.; Glees, J.P.; Baker, J.; Ford, H.T. 1985: Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer Cancer Treatment Reports 69(1): 43-46
Wilkening, M.; Letourneau, B.; Lassauniere, J.M.; Freysz, M. 1988: Perispinal morphine injections in the treatment of thoraco-abdominal cancer pain Presse Medicale 17(6): 284
Lehtonen, T.; Mäntylä, M. 1979: Treatment of prostatic cancer Duodecim; Laaketieteellinen Aikakauskirja 95(12): 760-767
Ogreid, P. 1986: Prostatic cancer. Treatment with LH-RH analogs Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(34-36): 2968-2970
Rutkowski, A. 1980: Problems of treatment of prostatic cancer Wiadomosci Lekarskie 33(18): 1461-1466
Fosså, S.D.; Miller, A. 1975: Treatment of advanced prostatic cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 95(13): 811-814
Ballanger, R.; Ballanger, P. 1980: Treatment of prostatic cancer with radiotherapy Acta Urologica Belgica 48(1): 86-91
Khazanov, V.G. 1989: The diagnosis and treatment of prostatic cancer Fel'dsher i Akusherka 54(6): 24-26
Paul, B.D.; Serrano, J.A.; Friedman, A.E.; Sarlos, I.J.; Sternberger, N.J.; Wasserkrug, H.L.; Seligman, A.M. 1977: New agents for prostatic cancer activated specifically by prostatic acid phosphatase Cancer Treatment Reports 61(2): 259-263
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Rodríguez Rodríguez, R.; Mayayo Dehesa, T.; Galbis Sanjuan, F.; Burgos Revilla, F.J.; Jiménez Cidre, M.; García González, R. 1996: Chronic prostatic inflammation: a confounding factor in the diagnosis of prostatic cancer Archivos Espanoles de Urologia 49(7): 669-673
Goldenberg, D.M.; DeLand, F.H. 1984: Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase Urologic Clinics of North America 11(2): 277-281
Hofland, L.J. 2003: Responsiveness to somatostatin analog treatment and potentials of novel somatostatin analog Journal of Endocrinological Investigation 26(8 Suppl): 8-13